FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ucb univasc Recall

univasc (moexipril HCl) tablets, 7

Ucb, Inc · Smyrna, GA

Risk level
Class II
Reported by FDA
Aug 26, 2015
Recall ID
D-1348-2015
Check your lot numberHow we source this data

Summary

Ucb recalled univasc starting Jul 24, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1348-2015 on Aug 26, 2015. Reason: Failed Dissolution Testing: Failed 24 month dissolution testing. Status: Terminated.

Why it was recalled

Failed Dissolution Testing: Failed 24 month dissolution testing.

Product description

univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01.

Lot numbers, UPCs & expiration codes

Lot #: 98016P1, Expiry: April, 2016

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1348-2015
Classification
Class II
Status
Terminated
Recall initiated
Jul 24, 2015
FDA report date
Aug 26, 2015
Quantity
2,916 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ucb, Inc

Original FDA data

Every field from FDA enforcement report D-1348-2015, exactly as published.

Show all FDA fields
City
Smyrna
State
GA
Status
Terminated
Country
United States
Event ID
71986
Address
1950 Lake Park Dr Se
Code information
Lot #: 98016P1, Expiry: April, 2016
Postal code
30080-7648
Report date
Aug 26, 2015
Product type
Drugs
Recall number
D-1348-2015
Classification
Class II
Recalling firm
Ucb, Inc
Product quantity
2,916 Bottles
Termination date
Jul 19, 2017
Reason for recall
Failed Dissolution Testing: Failed 24 month dissolution testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01.
Distribution pattern
U.S. Nationwide
Recall initiation date
Jul 24, 2015
Initial firm notification
Letter
Center classification date
Aug 19, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1348-2015, published Aug 26, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls